[:fr]

Abstract

Objectives: To prospectively assess the role of the US attenuation imaging coefficient (AC) for the diagnosis and quantification of hepatic steatosis.

Methods: One hundred and one patients underwent liver biopsy and US-AC measurement on the same day. Liver steatosis was graded according to biopsy as absent (S0 < 5%), mild (S1 5-33%), moderate (S2 33-66%), or severe (S3 > 66%); liver fibrosis was graded from F0 to F4. The correlation between AC and steatosis on pathology (%) was calculated using the Pearson correlation coefficient. The Student t or Mann-Whitney U test was used to compare continuous variables and ROC curve analysis was used to assess diagnostic performance of AC in diagnosing steatosis.

Results: Overall, 43 (42%), 35 (35%), 12 (12%), and 11 (11%) patients were classified as S0, S1, S2, and S3, respectively. The AC was positively correlated with steatosis as a continuous variable (%) on pathology (r = 0.58, p < 0.01). Patients with steatosis of any grade had a higher AC than those without steatosis (mean 0.77 ± 0.13 vs. 0.63 ± 0.09 dB/cm/MHz, respectively; p < 0.01, AUROC = 0.805). Patients with S2-S3 had a higher AC than patients with S0-1 (0.85 ± 0.11 vs. 0.67 ± 0.11 dB/cm/MHz, respectively; p < 0.01, AUROC = 0.892). AC > 0.69 dB/cm/MHz had a sensitivity and specificity of 76% and 86%, respectively, for diagnosing any grade of steatosis (S1-S3), and AC > 0.72 dB/cm/MHz had a sensitivity and specificity of 96% and 74%, respectively, for diagnosing S2-S3. The presence of advanced fibrosis (F3-F4) did not affect the calculated AC.

Conclusions: The attenuation imaging coefficient is a promising quantitative technique for the non-invasive diagnosis and quantification of hepatic steatosis.

Key points: • Measurement of the attenuation coefficient is achieved with a very high rate of technical success. • We found a significant positive correlation between the attenuation coefficient and the grade of steatosis on pathology. • The attenuation imaging coefficient is a promising quantitative technique for the noninvasive diagnosis and quantification of hepatic steatosis.

[:]

Autres publications

Auteurs :
Maxime Nachit,
Dioguardi Burgio Marco,
Abyzov Anton,
Garteiser Philippe,
Paradis Valérie,
Vilgrain Valérie,
Isabelle Leclercq,
Van Beers Bernard,
En savoir +
Auteurs :
Page Gwenael,
Julea Felicia,
Paradis Valérie,
Vilgrain Valérie,
Valla Dominique,
Van Beers Bernard,
Garteiser Philippe,
En savoir +
Date de publication :
26 Jan 2022
Auteurs :
[:fr]Tardieu M[:],
[:fr]Salameh N[:],
[:fr]Souris L[:],
[:fr]Rousseau D[:],
[:fr]Jourdain L[:],
[:fr]Skeif H[:],
[:fr]Prévot F[:],
[:fr]de Rochefort L[:],
[:fr]Ducreux D[:],
[:fr]Louis B[:],
Garteiser Philippe,
[:fr]Sinkus R[:],
[:fr]Darrasse L[:],
[:fr]Poirier-Quinot M[:],
[:fr]Maître X[:],
En savoir +
Auteurs :
Garteiser Philippe,
Castera Laurent,
Coupaye Muriel,
Doblas Sabrina,
Calabrese Daniela,
Dioguardi Burgio Marco,
Ledoux Séverine,
Bedossa Pierre,
[:fr]Marina Esposito-Farèse[:],
Msika Simon,
Van Beers Bernard,
[:fr]Pauline Jouët[:],
En savoir +